Bharat Biotech International Limited is an Indian biotechnology company headquartered in Hyderabad, India engaged in the drug discovery, drug development, manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. Read More
Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday. ...
Delhi government on Friday told the Delhi High Court that Bharat Biotech supplied only 1.5 lakh doses of COVID-19 vaccine 'Covaxin' in May against a promise of five lakh doses. ...
Hyderabad, June 3 Biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights to Bharat Biotech's Covaxin ... ...
Hyderabad-based Bharat Biotech on Thursday said that biopharmaceutical company Ocugen Inc will have exclusive co-development, manufacturing, and commercialisation rights of its COVID-19 vaccine Covaxin in Canada, in addition to its existing United St ...
New Delhi, June 3 Snowman Logistics, Indias leading integrated temperature-controlled logistics service provider, in a strategic partnership with ... ...
The health ministry has finalised arrangements with Hyderabad-based vaccine manufacturer Biological-E to book 30 crore COVID-19 vaccine doses, set to be manufactured and stockpiled from August to December this year. ...
It's a precarious situation when vaccine is the only weapon against the deadly Covid-19 and the state governments are floating global tenders to procure COVID-19 vaccine, there have been several cases where wastage of vaccine doses has been reported ...